Anti‐Amyloid Prescribing in Alzheimer's Disease: Ohio State University Clinical Guidelines for Patient Selection, Assessments, and Management

Abstract

Anti‐amyloid monoclonal antibodies are approved for use in patients with Mild Cognitive Impairment due to Alzheimer's disease (MCI‐AD) or mild AD dementia (ADD).

The paper